Furthermore, the present study demonstrated that elevated serum levels of NSE, but not ACE or sIL-2R, were significantly correlated with OCS use in sarcoidosis patients, which is consistent with previous findings that elevated levels of NSE have been related to increased systemic inflammation [17, 18]. The gene discussed is ACE; the disease is sarcoidosis.